SARS-CoV-2-specific CD4+ T cell response frequencies were not significantly different between cases of mild (non-hospitalized) and moderate to severe (previously hospitalized) COVID-19 when normalized to total CD4+ T cells in circulation, though the trend appeared to be toward increased frequencies of SARS-CoV-2-specific cells in the more severe cases. This evidence concerns the gene CD4 and COVID-19.